515 related articles for article (PubMed ID: 17678732)
21. Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group.
Simonton CA; Brodie B; Cheek B; Krainin F; Metzger C; Hermiller J; Juk S; Duffy P; Humphrey A; Nussbaum M; Laurent S;
J Am Coll Cardiol; 2007 Sep; 50(13):1214-22. PubMed ID: 17888837
[TBL] [Abstract][Full Text] [Related]
22. Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients.
Kumar R; Lee TT; Jeremias A; Ruisi CP; Sylvia B; Magallon J; Kirtane AJ; Bigelow B; Abrahamson M; Pinto DS; Ho KK; Cohen DJ; Carrozza JP; Cutlip DE
Am J Cardiol; 2007 Oct; 100(8):1187-91. PubMed ID: 17920355
[TBL] [Abstract][Full Text] [Related]
23. Adverse clinical events in patients treated with sirolimus-eluting stents: the impact of Type D personality.
Pedersen SS; Denollet J; Ong AT; Sonnenschein K; Erdman RA; Serruys PW; van Domburg RT
Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):135-40. PubMed ID: 17301639
[TBL] [Abstract][Full Text] [Related]
24. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents.
Spaulding C; Daemen J; Boersma E; Cutlip DE; Serruys PW
N Engl J Med; 2007 Mar; 356(10):989-97. PubMed ID: 17296825
[TBL] [Abstract][Full Text] [Related]
25. Impact of treatment of coronary artery disease with sirolimus-eluting stents on outcomes of diabetic and nondiabetic patients.
Kuchulakanti PK; Torguson R; Canos D; Rha SW; Chu WW; Clavijo L; Deible R; Gevorkian N; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
Am J Cardiol; 2005 Oct; 96(8):1100-6. PubMed ID: 16214445
[TBL] [Abstract][Full Text] [Related]
26. Incidence and predictors of target vessel revascularization and clinical event rates of the sirolimus-eluting coronary stent (results from the prospective multicenter German Cypher Stent Registry).
Zahn R; Hamm CW; Schneider S; Zeymer U; Nienaber CA; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Sabin G; Senges J;
Am J Cardiol; 2005 Jun; 95(11):1302-8. PubMed ID: 15904633
[TBL] [Abstract][Full Text] [Related]
27. In-hospital complications and long-term outcomes of the paclitaxel drug-eluting stent in acute ST-elevation myocardial infarction: a real-world experience from a high-volume medical center.
Shammas NW; Shammas GA; Hahn A; Jerin M; Dippel EJ; Winter M
Cardiovasc Revasc Med; 2009; 10(3):151-5. PubMed ID: 19595395
[TBL] [Abstract][Full Text] [Related]
28. Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries.
Lasala JM; Cox DA; Dobies D; Baran K; Bachinsky WB; Rogers EW; Breall JA; Lewis DH; Song A; Starzyk RM; Mascioli SR; Dawkins KD; Baim DS;
Circ Cardiovasc Interv; 2009 Aug; 2(4):285-93. PubMed ID: 20031730
[TBL] [Abstract][Full Text] [Related]
29. Outcomes after sirolimus- and paclitaxel-eluting stent implantation in patients with insulin-treated diabetes mellitus.
Buch AN; Javaid A; Steinberg DH; Roy P; Pinto Slottow TL; Xue Z; Smith K; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
Am J Cardiol; 2008 May; 101(9):1253-8. PubMed ID: 18435953
[TBL] [Abstract][Full Text] [Related]
30. Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial.
Morice MC; Serruys PW; Barragan P; Bode C; Van Es GA; Stoll HP; Snead D; Mauri L; Cutlip DE; Sousa E
J Am Coll Cardiol; 2007 Oct; 50(14):1299-304. PubMed ID: 17903626
[TBL] [Abstract][Full Text] [Related]
31. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up.
Park DW; Park SW; Park KH; Lee BK; Kim YH; Lee CW; Hong MK; Kim JJ; Park SJ
Am J Cardiol; 2006 Aug; 98(3):352-6. PubMed ID: 16860022
[TBL] [Abstract][Full Text] [Related]
32. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
[TBL] [Abstract][Full Text] [Related]
33. Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Alfonso F; Pérez-Vizcayno MJ; Hernández R; Bethencourt A; Martí V; López-Mínguez JR; Angel J; Iñiguez A; Morís C; Cequier A; Sabaté M; Escaned J; Jiménez-Quevedo P; Bañuelos C; Suárez A; Macaya C;
J Am Coll Cardiol; 2008 Nov; 52(20):1621-7. PubMed ID: 18992651
[TBL] [Abstract][Full Text] [Related]
34. Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos).
de la Torre-Hernández JM; Alfonso F; Hernández F; Elizaga J; Sanmartin M; Pinar E; Lozano I; Vazquez JM; Botas J; Perez de Prado A; Hernández JM; Sanchis J; Nodar JM; Gomez-Jaume A; Larman M; Diarte JA; Rodríguez-Collado J; Rumoroso JR; Lopez-Minguez JR; Mauri J;
J Am Coll Cardiol; 2008 Mar; 51(10):986-90. PubMed ID: 18325436
[TBL] [Abstract][Full Text] [Related]
35. Two-year clinical outcome after successful implantation of drug-eluting and bare metal stents in diabetic patients: results from a real-world single center registry.
Dou KF; Xu B; Yang YJ; Chen JL; Qiao SB; Li JJ; Qin XW; Liu HB; Wu YJ; Chen J; Yao M; You SJ; Yuan JQ; Dai J; Gao RL
Chin Med J (Engl); 2009 Mar; 122(6):612-6. PubMed ID: 19323921
[TBL] [Abstract][Full Text] [Related]
36. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
[TBL] [Abstract][Full Text] [Related]
37. Stent thrombosis: a poor man's disease?
Danenberg HD; Marincheva G; Varshitzki B; Nassar H; Lotan C
Isr Med Assoc J; 2009 Sep; 11(9):529-32. PubMed ID: 19960845
[TBL] [Abstract][Full Text] [Related]
38. Sirolimus-eluting stent implantation in diabetic patients with multivessel coronary artery disease.
Briguori C; Colombo A; Airoldi F; Focaccio A; Iakovou I; Chieffo A; Michev I; Montorfano M; Bonizzoni E; Ricciardelli B; Condorelli G
Am Heart J; 2005 Oct; 150(4):807-13. PubMed ID: 16209986
[TBL] [Abstract][Full Text] [Related]
39. Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.
Piscione F; Piccolo R; Cassese S; Galasso G; Chiariello M
Catheter Cardiovasc Interv; 2009 Aug; 74(2):323-32. PubMed ID: 19360858
[TBL] [Abstract][Full Text] [Related]
40. Sirolimus-eluting stent treatment at high-volume centers confers lower mortality at 6-month follow-up: results from the prospective multicenter German Cypher Registry.
Khattab AA; Hamm CW; Senges J; Toelg R; Geist V; Bonzel T; Kelm M; Levenson B; Nienaber CA; Pfannebecker T; Sabin G; Schneider S; Tebbe U; Neumann FJ; Richardt G;
Circulation; 2009 Aug; 120(7):600-6. PubMed ID: 19652087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]